The new model of access strategy should build around four key pillars, says Jeff Weisel, Senior Advisor Asia-Pacific, PRMA Consulting. In this update, Jeff explores why the shifting currents of global healthcare are dictating a new approach to market access. Continue Reading
Gathering experts and soliciting their advice is a time-honored tactic. But methods for doing so invariably involve meeting in person. Although the threat of COVID-19 appears to be slowly receding, business travel may take years to return to pre-crisis levels.… Continue Reading
Since COVID-19 first emerged as a global pandemic, the pharmaceutical industry has risen to meet the virus’ related challenges from a prevention as well as a treatment perspective. Continue Reading
The COVID-19 pandemic has been characterized by surges in infections in different parts of the country at different times. The most recent rebound of COVID cases, however, indicates that the COVID-19 pandemic is not just a series of isolated surges that is “one and done.” Continue Reading
19. As in COVID. Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. Continue Reading
